Oral Cancer Diagnostics Market Top Leading Players with Strategies and Forecast 2027

 


The Global Oral Cancer Diagnostics Market is expected to register a CAGR of 6.94% during the forecast period with a market value of USD 7,367.90 Million till 2024. Oral cancer is a broad category that includes a number of conditions such as cancers of lips, tongue, cheeks, hard and soft palate, the floor of the mouth, pharynx, and sinuses. Early diagnosis of oral cancer is extremely crucial as the treatment of the disease is dependent on the stage of cancer, and earlier the diagnosis, the easier it is to manage the cancerous growth.

The increase in the patient population, effective diagnostic aids in the detection of oral cancer coupled with the advances in research and rise in risk factors is anticipated to drive the market growth. However, the lack of trained professionals and the unaffordability of healthcare organizations to purchase new imaging systems is likely to hamper the market growth.

Get Sample Report: https://www.marketresearchfuture.com/sample_request/8086

Segment Analysis

The global oral cancer diagnostics market, by indication, has been segmented into oral squamous cell carcinoma, oral verrucous carcinoma, mucoepidermoid carcinoma (salivary gland), oral cavity lymphomas, and others. Based on diagnosis type, the oral cancer diagnostics market has been categorized as endoscopy, biopsy, X-ray, computed tomography (CT) scans, positron emission tomography (PET), magnetic resonance imaging (MRI), ultrasonography, fluorescence imaging, and others. Based on end user, the oral cancer diagnostics market has been segmented into hospitals and clinics, research and academic institutes, and others.

Market Players

MRFR recognizes the following companies as the key players in the global oral cancer diagnostics market GE Healthcare (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Siemens Healthineers (Germany), Hitachi Ltd (Japan), PeriRx, LLC (US), Canon Medical Systems Corporation (Japan), Vigilant Biosciences, Inc. (US), QIAGEN (Germany), and Koninklijke Philips NV (Netherlands).

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/oral-cancer-diagnostics-market-8086

Regional Analysis

The global oral cancer diagnostics market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global oral cancer diagnostics market. This is owing to the presence of key market players, well-developed healthcare infrastructure, the growing incidence of oral cancer, and favorable reimbursement policies in the US and Canada.

The Europe market demonstrated substantial growth in the market due to increasing government support for research & development, availability of funds for research, growing geriatric population coupled with rising cases of cancer, and increasing adoption of medical diagnostic equipment. As per the data published by the World Health Organization (WHO), in 2018, there were 61,885 new oral cancer cases and 24,063 deaths caused by oral cancer in Europe.

Asia-Pacific is estimated to be the fastest growing region in the global market due to rapidly developing medical technology, the presence of a huge patient population, growing awareness of cancer and diagnostic modalities, and increasing expenditure in healthcare by the government. India held a share of 34.34% in the Asia-Pacific oral cancer diagnostics market in 2018.

The oral cancer diagnostics market in the Middle East & Africa is expected to grow due to the rising awareness about cancer diagnostics coupled with gradually increasing adoption of medical diagnosis modalities in the region.

 

Key Findings of the Study

·         The global oral cancer diagnostics market was valued at USD 4,909.60 million in 2018, is estimated to grow at USD 7,367.90 Million by 2024 at a CAGR of 6.94% during the assessment period

·         Americas accounted for the largest share of the global market due to the presence of key market players and an increasing patient population in the US and Canada

·         Based on indication, the oral squamous cell carcinoma segment accounted for the largest market share of 02% in 2018

·         Based on the diagnosis type, the computed tomography (CT) segment held a major market value of USD 1,476.13 million in 2018

·         On the basis of the end user, the hospitals and clinics segment dominated the market and accounted for a share of 81% in 2018

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Comments

Post a Comment

Popular posts from this blog

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Dental Chair Market Growth and Restrain Factors Analysis Report 2022

Image
  The global Dental Chair Market is witnessing a continual rise. Market growth attributes to growing dental issues and dental practices across the globe. Besides, improvements in the functionality of dental chairs drive the growth of the market. Dental chairs play a causal role in improving the patient experience during dental treatments. Increased patient comfort during performing dental procedures and dental surgeries act as a significant growth driver. Global Dental Chair Market – Segmentation The report is segmented into four dynamics; ·          By Product : Powered Dental Chairs and Non-Powered Dental Chairs. ·          By Type : Fixed Dental Chair and Portable Dental Chair. ·          By Application : Examination, Oral Surgery, Orthodontics, and others. ·          By Regions :   North America, Euro...
Read more